Luomalla maksuttoman Inderes-tilin, pääset käsiksi Inderesin analyysiin, voit tilata suositun aamukatsauksen ja seurata sinua kiinnostavia yhtiöitä sekä keskusteluita.
Onko sinulla jo Inderes-tili?
Follow this company like 379 other investors.
New initiatives to grow subscription sales in the pipelineSeasonality changes and adding new revenue streamShare trading at 15.5x EV/EBITDA for 2023eLower Virtual Care sales, but subscribers are set to growThe Q1 results came in slightly below our ex
Q1 sales of EUR 2.6m (-5.7% vs ABGSC)The number of subscribers +17% y-o-y (vs ABGSC 21%)Expect relatively small forecasts changesQ1 resultsSales EUR 2.6m (-5.7% vs ABGSC 2.7m and -8.0% vs cons 2.8m), EBITDA EUR 0.3m (-38.0% vs ABGSC 0.4m), Adj.
Physitrack stays strong despite external disruptions We add Champion Health to the figuresShare trades more than 40% below Nordic SaaS peersM&A agenda continues strongly – three acquisitions in H1 Since Physitrack is not exposed to external facto
Acquires a leading digital workplace health platformAdding (at least) 3.2% to sales in ’22ePays 7.3x EV/sales, based on run rate sales of EUR 0.4mChampion Health - a leading workplace health platform Physitrack has acquired Champion Health, a leading
SaaS platform with a range of solutions for physiotherapy Organic sales CAGR of 24% in ’20/’21-’24eShare price range: SEK 42-69, 11x-17x ’23e EV/EBITDARecurring revenues, strong growth and EBITDA marginPhysitrack provides a digital platform with a wi